Last updated on July 2018

BGB 3111 in Combination With Obinutuzumab in Subjects With B-Cell Lymphoid Malignancies

Brief description of study

This study is evaluating the safety and preliminary efficacy of BGB-3111 in combination with obinutuzumab in subjects with B-cell lymphoid malignancies.

Clinical Study Identifier: NCT02569476

Contact Investigators or Research Sites near you

Start Over

William Novonty, MD

The Alfred Hospital
Melbourne, Australia

William Novonty, MD

St Frances Xavier Cabrini Hospital
Malvern, Australia

William Novonty, MD

St Vincent's Hospital Melbourne
East Melbourne, Australia